TH98586A - Oral liquid medicine - Google Patents
Oral liquid medicineInfo
- Publication number
- TH98586A TH98586A TH601006567A TH0601006567A TH98586A TH 98586 A TH98586 A TH 98586A TH 601006567 A TH601006567 A TH 601006567A TH 0601006567 A TH0601006567 A TH 0601006567A TH 98586 A TH98586 A TH 98586A
- Authority
- TH
- Thailand
- Prior art keywords
- oral liquid
- dichloroacetate
- liquid medicine
- oral
- diisopo
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims abstract 6
- 239000007788 liquid Substances 0.000 title claims abstract 6
- 229940079593 drugs Drugs 0.000 claims abstract 5
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N 2,2-dichloroacetate;di(propan-2-yl)azanium Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 claims abstract 3
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 claims abstract 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N Diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 claims 2
- PHOQVHQSTUBQQK-SQOUGZDYSA-N Glucono δ-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 claims 2
- 229960003681 Gluconolactone Drugs 0.000 claims 2
- 235000012209 glucono delta-lactone Nutrition 0.000 claims 2
- 229940089960 Chloroacetate Drugs 0.000 claims 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-M chloroacetate Chemical compound [O-]C(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-M 0.000 claims 1
- 229940043279 diisopropylamine Drugs 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- -1 Propylamine dichloroacetate Chemical compound 0.000 abstract 2
- 150000002596 lactones Chemical class 0.000 abstract 2
- 239000004575 stone Substances 0.000 abstract 2
- 230000003389 potentiating Effects 0.000 abstract 1
Abstract
DC60 (07/03/50) การประดิษฐ์นี้เกี่ยวกับยาน้ำสำหรับใช้รับประทานที่มีจุดเด่นอยู่ที่มีส่วนผสมของกลูโคลโน แลคโตนและไดไอโซโพรพีลอะมีนไดคลอโรอะซิเตต pH ของยาน้ำสำหรับใช้รับประทานที่ระบุข้างต้นที่ ผลิตได้ เป็น 1.5 - 3.0 จึงจะเหมาะสม อัตราส่วนผสมระหว่างกลูโคลโนแลคโตนและไดไอโซโพ รพีลอะมีนไดคลอโรอะซิเตตเป็น 31 - 340:1 จึงจะเหมาะสม การประดิษฐ์นี้เกี่ยวกับยาน้ำสำหรับใช้รับประทานที่มีจุดเด่นอยู่ที่มีส่วนผสมของกลูโคลโน แลคโตนและไดไอโซโพรพีลอะมีนไดคลอโรอะซิเตต pH ของยาน้ำสำหรับใช้รับประทานที่ระบุข้างต้นที่ ผลิตได้ เป็น 1.5 - 3.0 จึงจะเหมาะสม อัตราส่วนผสมระหว่างกลูโคลโนแลคโตนและไดไอโซโพ รพีลอะมีนไดคลอโรอะซิเตตเป็น 3:1 - 340:1 จึงจะเหมาะสม: สิทธิบัตรยา DC60 (07/03/50) This invention is about a potent oral liquid containing gluconol. Lactone and Diisopropylamine Dichloroacetate The pH of the oral aqueous drugs indicated above produced 1.5 - 3.0 is suitable. Stone and Diisopo Propylamine dichloroacetate is 31 - 340: 1, so it would be appropriate. This invention involves a highly functional oral liquid containing gluconol. Lactone and Diisopropylamine Dichloroacetate The pH of the oral aqueous drugs indicated above produced 1.5 - 3.0 is suitable. Stone and Diisopo Propylamine dichloroacetate is 3: 1 - 340: 1, therefore suitable: drug patent.
Claims (3)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH98586B TH98586B (en) | 2009-10-12 |
| TH98586A true TH98586A (en) | 2009-10-12 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201070121A1 (en) | DOSAGE FORM CONTAINING A SLIP PROTEIN GLP-1-FC | |
| WO2007125501A3 (en) | Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness | |
| EA201300465A1 (en) | SUSTAINABLE ORAL PHARMACEUTICAL DOSED FORMS CONTAINING OPIOID ANALGETIC | |
| NI201000104A (en) | PHARMACEUTICALLY ACCEPTABLE SALTS OF (3 - {[[3- (6-AMINO-2-BUTOXI-8- 0X0-7,8-DIHYDRO-9H-PURIN-9-lL) PROPYL] (3-MORFOLIN-4-lLPROPIL) AMINOWETIL} FENYL) METHYL ACETATE AND ITS USES IN THERAPY. | |
| WO2006094974A3 (en) | Chemically defined stabiliser composition | |
| TW200716202A (en) | Pediatric formulation of topiramate | |
| PL1750700T3 (en) | Liquid preparation for veterinary medicine, method for the production thereof, and use of the same | |
| DK2013166T3 (en) | N-carbamoylmethyl-4 (R) -phenyl-2-pyrrolidone, process for its preparation and pharmaceutical use | |
| ATE492271T1 (en) | METHOD FOR PRODUCING A DRUG EXTRACT CONTAINING HYDROXYSTILBENE | |
| MX2011006797A (en) | Formulation for delivering lipid-lowering drugs by oral transmucosal administration. | |
| HK1120417A1 (en) | Stable nanoparticle formulations | |
| DK1830814T3 (en) | Taste masked formulation for non-plasticizing drugs | |
| TH98586A (en) | Oral liquid medicine | |
| DK1906921T3 (en) | Clear pharmaceutical aqueous microemulsion comprising propofol and method of preparation | |
| GB2443377A (en) | Anti-malarial composition comprising artesunate and lumefantrine | |
| TH98586B (en) | Oral liquid medicine | |
| UA94042C2 (en) | Use of agomelatine for the preparation of drugs to treat smith magenis syndrome | |
| IL182835A0 (en) | Process for and imtermediates in the preparaition of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents | |
| FR2901137B1 (en) | NOVEL GALENIC FORMS OF NATURAL INHIBITORS OF PROTEASIC ENZYMES, QUAY EGG EXTRACTS ASSOCIATED WITH VITAMINS OR / AND MINERALS, AMINO ACIDS INCORPORATED INTO AN EXCIPIENT. | |
| WO2008071869A3 (en) | Use of agomelatine in order to obtain drugs intended for the treatment of periventricular leukomalacia | |
| EP1967188A4 (en) | Pharmaceutical preparation of aqueous solution containing platinum complex | |
| UA87524C2 (en) | Benzothiazole formulations with a macrogol glyceride and use thereof | |
| TH152252A (en) | Cyclopropyl-oxopyranylbenzamid | |
| WO2007099431A3 (en) | An aqueous liquid pharmaceutical compositions of gatifloxacin | |
| TH152680A (en) | Spirocyclic derivatives App for the treatment of lung disease |